Foster Jonathan P. Insider Trading Activity

Average Profitability
13.07%
Insider Buys Quantity
6
Insider Buys Sum
$99,103.02
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Foster Jonathan P.

According to the SEC Form 4 filings, Foster Jonathan P., being in a position of

  1. Chief Financial Officer at Moleculin Biotech, Inc.,
    оver the last 12 months, has bought 293333 shares for $220,000, and sold 0 shares,
    over all time since 2017-04-25, has bought 612589 shares for $357,298, and sold 0 shares.

Biography of Foster Jonathan P.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $220,0001100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-08-03PurchaseMoleculin Biotech, Inc.
MBRX
Chief Financial Officer
293,333
12.5506%
$0.75$220,000+22.82%
2025-06-23PurchaseMoleculin Biotech, Inc.
MBRX
Chief Financial Officer
270,270
2.5843%
$0.37$100,000-31.68%
2023-12-26PurchaseMoleculin Biotech, Inc.
MBRX
Chief Financial Officer
28,986
0.1032%
$0.69$20,000-59.21%
2017-04-25PurchaseMoleculin Biotech, Inc.
MBRX
Exec. Vice President & CFO
20,000
0.1113%
$0.86$17,298+114.94%
2015-08-18PurchaseInfuSystem Holdings, Inc.
INFU
Chief Financial Officer
2,000
0.009%
$2.92$5,8400%
2015-06-15PurchaseInfuSystem Holdings, Inc.
INFU
Chief Financial Officer
624
0.0027%
$3.12$1,947-4.72%
2015-05-15PurchaseInfuSystem Holdings, Inc.
INFU
Chief Financial Officer
8,540
0.0366%
$3.07$26,218-4.06%
2014-03-13PurchaseInfuSystem Holdings, Inc.
INFU
Chief Financial Officer
10,000
0.0463%
$2.78$27,800+1.83%
Total: 8
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.